Reference
Takeuchi M, et al. HLA-DRB1*04:05 is involved in the development of Vogt-Koyanagi-Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors. Scientific Reports 13: No. 1, 21 Aug 2023. Available from: URL: http://doi.org/10.1038/s41598-023-40565-z
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1975, 46 (2023). https://doi.org/10.1007/s40278-023-46401-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-46401-9